Latest Analysis

The latest in federal health policy.


Subcommittee Considers How to Bolster Hospital Price Transparency and Increase Provider Competition; Discusses PBMs, Site-Neutral Payments, and 340B

The House Energy & Commerce Committee Health Subcommittee held a hearing on ways to promote transparency and competition in health care. Members presented a largely bipartisan front, focusing on asking witnesses ways to improve the Hospital Price Transparency Final Rule and the Transparency in Coverage Final Rule and how to address provider consolidation. All witnesses agreed that the hospital price… (McClurg, March 29, 2023) #340B, #Costs, #Hospitals, #Pharmacy Benefit Managers

Agency Announces Funding Opportunity for Certified Community Behavioral Health Clinics Providing Mental Health and Substance Use Disorder Care

The Department of Health and Human Services (HHS), through Substance Abuse and Mental Health Services Administration (SAMHSA), announced two funding opportunities, worth $123.6 million, for Certified Community Behavioral Health Clinics (CCBHCs) expansion. The CCBHC Planning, Development, and Implementation (CCBHC-PDI) grant will help establish new CCBHC programs, while the CCBHC Improvement and Advancement (CCBHC-IA) grant aims to enhance existing CCBHCs that… (Colocho, March 28, 2023) #Community Health Centers, #Health Equity, #Mental and Behavioral Health, #Opioids, #Prevention, #Public Option

Nominations for National Advisory Council Due May 26

The Agency for Healthcare Research and Quality (AHRQ) issued a request for nominations for new members of the National Advisory Council for Healthcare Research and Quality (Council) which advises the Secretary of Health and Human Services (HHS) and the Director of AHRQ on national health services research priorities. Seven new members are sought to replace seven members whose terms expire… (Testa, March 27, 2023) #Quality

Draft Guidance Issued on Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics

The Food and Drug Administration (FDA) issued draft guidance on clinical trial considerations to support accelerated approval of oncology therapeutics. The FDA asserts that while single-arm trials have been commonly used to support accelerated approval, a randomized controlled trial is the preferred approach as it provides a more robust efficacy and safety assessment and allows for direct comparison to an… (Slifer, March 24, 2023) #Food and Drug Administration, #Prescription Drugs

White House Announces the Challenge to End Hunger and Build Healthy Communities

The Biden-Harris Administration launched the new White House Challenge to End Hunger and Build Healthy Communities to strengthen public-private partnerships that improve nutrition and diet-related diseases. This Challenge is intended to implement the priorities of the White House Conference on Nutrition, Hunger, and Health in September 2022 (WHG summary) and the National Strategy on Hunger, Nutrition, and Health. The Administration,… (McClurg, March 24, 2023) #Health Equity, #Nutrition

Sen. Peters Releases Report on Critical Medication Shortages and National Security Risk

Chairman of the Senate Homeland Security and Governmental Affairs Committee Gary Peters (D-MI) released a report that found continued shortages of critical medications due to economic drivers, insufficient visibility into supply chains, increased demand, and an overreliance on foreign suppliers (full report). The report shows that drug shortages and lack of transparency into pharmaceutical supply chains present a national security… (Colocho, March 23, 2023) #Drug Pricing, #Food and Drug Administration, #Generic Drugs, #Transparency

Become a PolicyHub member for full access to our latest analysis. Learn about all the health issues we cover, from A to Z.